Sign In
Buy GRF
$10.08
-0.370 (-3.54%)
At Close: Jul 31, 2026
Grifols presents additional encouraging Alzheimer's trial results at AAIC
06:39am, Tuesday, 16'th Jul 2019
BARCELONA, Spain, July 16, 2019 /PRNewswire/ -- The Grifols Clinical Research team, led by Dr. Antonio Páez, today presented additional results of its AMBAR (Alzheimer Management by Albumin Replacem
Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies
03:51pm, Thursday, 04'th Jul 2019
BARCELONA, Spain, July 4, 2019 /PRNewswire/ -- Grifols (GRF.MC) (GRF.P.MC) (GRFS), a leading global producer of plasma-derived medicines, announced today that Xembify®, its new 20% subcutaneous immun
Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa
09:00am, Wednesday, 03'rd Jul 2019
BARCELONA, Spain, July 3, 2019 /PRNewswire/ -- Grifols (GRF.MC) (GRF.P.MC) (GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, today announce
Grifols to launch plasma-protein-based bleeding-control solutions
01:00pm, Wednesday, 19'th Jun 2019
BARCELONA, Spain, June 19, 2019 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), one of the world's three top providers of plasma-derived medicines to treat life-threatening diseases, tod
The Chemist's Closed-End Fund Report - March 2019: Fixed Income CEFs Strike Back
05:58pm, Tuesday, 09'th Apr 2019
No summary available.
Weekly Closed-End Fund Roundup: More Boosters Than Cutters, EXD New Strategy Live
10:25pm, Monday, 25'th Feb 2019
No summary available.
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
02:09pm, Friday, 23'rd Nov 2018Look To Consumer Discretionary For The Next Big Opportunity (XLY) - ETF Daily News
04:10pm, Monday, 09'th Jul 2018
From Contrarian Outlook: It’s here again: another stock downturn. But don’t worry, because today I’m going to show you a “1-click” way to profit from it (and collect a nice 6.8% dividend whi
